LLY·Healthcare·Pharma
Eli Lilly Weight Loss +5.2%: Rally Following Study Shock at Novo Nordisk
Eli Lilly Weight Loss: Stock jumps after weaker CagriSema data from Novo Nordisk – what does the rally mean for…
LLY·Healthcare·Pharma
Eli Lilly Weight Loss: Stock jumps after weaker CagriSema data from Novo Nordisk – what does the rally mean for…
ENEL.MI·Utilities
Enel's €53 billion investment plan, higher dividend, and buyback: How attractive is the stock after the rally?
CRM·Technology·AI
Salesforce quarter in focus: AI investments, margin pressure, and a stock decline of -4.3% – what’s next for the CRM…
NVDA·Technology·AI
NVIDIA quarter expected with $66B revenue: Does the AI boom continue or is a correction looming for investors?
NVO·Healthcare·Pharma
Novo Nordisk CagriSema misses against Tirzepatide in REDEFINE-4; stock plunges 15% in pre-market – what this means for investors.
AAPL·Technology·Magnificent 7
Apple tariff ruling brings billions in potential and margin boost, but China risk and new trade tariffs remain uncertainties.
MRK.DE·Healthcare
Merck dividend strategy in focus: Can the pipeline cushion the Keytruda patent cliff starting in 2028 for dividend hunters?
AMZN·Consumer Cyclical·Cloud Computing
Amazon's $200B AI investments strain free cash flow—are AWS, advertising, and AI assistants worth the cost?
LCID·Consumer Cyclical·EV & Mobility
Lucid Group Turnaround: Production +104%, Saudi billions, and strict cost-cutting – is that enough for the path to profitability?
TSLA·Consumer Cyclical·EV & Mobility
Tesla lowers Cybertruck prices, launches Cybercab, and faces Autopilot lawsuits – what does this mean for TSLA investors?